HemaQuest Pharmaceuticals Receives $4,000,000 Series B Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37c0f677-bbd5-4a15-be27-f940911161d4&Preview=1 - Date
7/28/2010 - Company Name
HemaQuest Pharmaceuticals - Mailing Address
1229 Madison Street Seattle, WA 98104 - Company Description
HemaQuest is a company developing proprietary small molecule therapeutics to treat serious blood disorders. - Website
http://www.hemaquest.com - Transaction Type
Venture Equity - Transaction Amount
$4,000,000 - Transaction Round
Series B - Proceeds Purposes
The financing will be used to help push HemaQuest’s two lead drug candidates through mid-stage clinical trials designed to show they are safe and effective. - M&A Terms
- Venture Investor
Latterell Venture Partners
